Pulsed radiofrequency therapy for managing neuropathic pain
Prospective Study Upon Pulsed Radiofrequency Therapy on Peripheral Nerves Monitoring Pain, Quality of Life, Patient Satisfaction and Efficacy
Amsterdam UMC, location VUmc · NCT06270940
This study is testing how well pulsed radiofrequency therapy can help people with chronic neuropathic pain feel better and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Amsterdam UMC, location VUmc (other) |
| Locations | 1 site (Amsterdam) |
| Trial ID | NCT06270940 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with chronic peripheral neuropathic pain who are scheduled to receive pulsed radiofrequency (PRF) treatment. The study aims to monitor pain levels, quality of life, patient satisfaction, and the efficacy of the PRF intervention. Patients will be recruited from an outpatient pain clinic, and their data will be collected using a secure electronic data capture system. Informed consent will be obtained from participants, ensuring ethical standards are met throughout the study.
Who should consider this trial
Good fit: Ideal candidates for this study are Dutch-speaking adults aged 18 and older with chronic peripheral neuropathic pain lasting at least six months and a mean pain score of four or higher.
Not a fit: Patients who are unable to complete the required questionnaires or do not meet the inclusion criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improve the quality of life for patients suffering from chronic neuropathic pain.
How similar studies have performed: Previous studies have shown promising results for pulsed radiofrequency treatment in managing chronic peripheral neuropathic pain, indicating that this approach has potential benefits.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients ≥ 18 * Dutch speaking * Chronic peripheral neuropathic pain lasting ≥ 6 months with mean NRS pain score of ≥ 4 * Patients who are scheduled for an ultrasound guided PRF treatment on a peripheral nerve * Willing and able to sign consent Exclusion Criteria: - Inability to complete the questionnaires
Where this trial is running
Amsterdam
- Amsterdam UMC — Amsterdam, Netherlands (RECRUITING)
Study contacts
- Principal investigator: Monique Steegers, Prof — Amsterdam UMC
- Study coordinator: Katrin Stoecklein, Dr
- Email: k.stoecklein@amsterdamumc.nl
- Phone: 0031 20 444 386
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neuropathic Pain